IRIS PubliCatt
PubliCatt è il repository istituzionale ad accesso aperto dell'Università Cattolica del Sacro Cuore, dove gli utenti autorizzati afferenti all'Ateneo provvedono direttamente e autonomamente a depositare e a rendere visibili le proprie pubblicazioni, inserendo i dati descrittivi del documento stesso ("metadati", quali il titolo, autore, abstract, etc.) e, laddove possibile, il testo della pubblicazione stessa (full-text).
PubliCatt utilizza la piattaforma IRIS (Institutional Research Information System) sviluppata da CINECA.
EnglishVarious grades of adverse events are associated with sorafenib and have recently been considered as a surrogate of response in patients with advanced hepatocellular carcinoma. The aim of this prospective study was to measure the efficacy of a sorafenib dose reduction regimen, adjusted on patient's tolerability, and aimed at increasing the exposure to the drug.
Ponziani, F. R., Gasbarrini, A., Inducing tolerability of adverse events increases sorafenib exposure and optimizes patient's outcome in advanced hepatocellular carcinoma, <<LIVER INTERNATIONAL>>, 2015; (Dicembre): N/A-N/A. [doi:10.1111/liv.13052] [http://hdl.handle.net/10807/70768]
| Autori: | |
| Titolo: | Inducing tolerability of adverse events increases sorafenib exposure and optimizes patient's outcome in advanced hepatocellular carcinoma |
| Digital Object Identifier (DOI): | http://dx.doi.org/10.1111/liv.13052 |
| Data di pubblicazione: | 2015 |
| Abstract: | Various grades of adverse events are associated with sorafenib and have recently been considered as a surrogate of response in patients with advanced hepatocellular carcinoma. The aim of this prospective study was to measure the efficacy of a sorafenib dose reduction regimen, adjusted on patient's tolerability, and aimed at increasing the exposure to the drug. |
| Lingua: | Inglese |
| Rivista: | |
| Citazione: | Ponziani, F. R., Gasbarrini, A., Inducing tolerability of adverse events increases sorafenib exposure and optimizes patient's outcome in advanced hepatocellular carcinoma, <<LIVER INTERNATIONAL>>, 2015; (Dicembre): N/A-N/A. [doi:10.1111/liv.13052] [http://hdl.handle.net/10807/70768] |
| Appare nelle tipologie: | Articolo in rivista, Nota a sentenza |
File in questo prodotto:
Copyright © 2020